Clinical Trials Browser

Phase 2 × Triple Negative Breast Neoplasms × Restraint, Physical × Clear all

NCT02750358 2025-06-22

Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer

Phase 2 Active not recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms